Adaptive Biotechnologies (ADPT) EBT Margin (2018 - 2026)
Adaptive Biotechnologies' (ADPT) quarterly EBT Margin came in at 22.65% in Q2 2026, up 2082.0% year-over-year from 1.04% in Q2 2025, and up 19.79% quarter-over-quarter from 28.24% in Q1 2026.
Powered by 
Analysis
Adaptive Biotechnologies (ADPT) EBT Margin (2018 - 2026) Analysis & Trends
Adaptive Biotechnologies has disclosed EBT Margin across 9 years of filings, most recently posting 22.65% for Q2 2026.
- In Q2 2026, EBT Margin rose 2082.0% year-over-year to 22.65%; the TTM figure through Jun 2026 stood at 13.07% (up 4601.0% YoY), while the FY2025 annual figure was 21.47%, up 6771.0% from the prior year.
- EBT Margin came in at 22.65% for Q2 2026 at Adaptive Biotechnologies, up from 28.24% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 10.16% in Q3 2025 to a low of 162.6% in Q1 2022.
- Average EBT Margin over 5 years is 83.65%, with a median of 83.76% recorded in 2022.
- Year-over-year, EBT Margin jumped 8899 bps in 2022 and plunged 7896 bps in 2023.
- Over 5 years, EBT Margin stood at 72.77% in 2022, then tumbled by 108 bps to 151.73% in 2023, then soared by 53 bps to 71.04% in 2024, then jumped by 73 bps to 18.94% in 2025, then retreated by 20 bps to 22.65% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 22.65% in Q2 2026, 28.24% in Q1 2026, and 18.94% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | -8.93% |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 13.54% |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 10.36% |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | -35.81% |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 2.30% |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | -0.23% |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 24.29% |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 6.87% |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | -22.65% |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | -0.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -22.65% |
| Mar 31, 2026 | -28.24% |
| Dec 31, 2025 | -18.94% |
| Sep 30, 2025 | 10.16% |
| Jun 30, 2025 | -43.47% |
| Mar 31, 2025 | -56.88% |
| Dec 31, 2024 | -71.04% |
| Sep 30, 2024 | -69.12% |
| Jun 30, 2024 | -107.08% |
| Mar 31, 2024 | -113.52% |
| Dec 31, 2023 | -151.73% |
| Sep 30, 2023 | -132.72% |
| Jun 30, 2023 | -97.72% |
| Mar 31, 2023 | -153.27% |
| Dec 31, 2022 | -72.77% |
| Sep 30, 2022 | -94.75% |
| Jun 30, 2022 | -119.29% |
| Mar 31, 2022 | -162.60% |
| Dec 31, 2021 | -161.76% |
| Sep 30, 2021 | -141.89% |